Development of a High‐Throughput Microarray Platform for Rapid, Low‐Cost Expanded Carrier Screening
ABSTRACT Objective To develop a customized expanded carrier screening (ECS) solution for 8271 variants of 265 genes. Based on a microarray platform, this solution demonstrates comparable accuracy to next‐generation sequencing (NGS) platform; however, it has a lower cost, a faster speed, and a simplified data—analysis process.
Jiazhen Chang +11 more
wiley +1 more source
Soil-derived microbiota induces T regulatory cells and protect against mouse colitis, metabolic disease, and sepsis. [PDF]
Szurek EA +12 more
europepmc +1 more source
Novel and High‐Throughput Method of Isolating Single Fetal Cells Using FACS for NIPT
ABSTRACT Objective To evaluate fluorescence activated cell sorting (FACS) as a method of single‐cell isolation of rare circulating fetal cells from maternal blood for use in cell‐based non‐invasive prenatal testing (cbNIPT). Method Blood samples (30 mL) were collected from 75 ‘low‐risk’ pregnant women (gestational age 10–15 weeks).
Ripudaman Singh +9 more
wiley +1 more source
A phenome-wide association study of CNVs genotyped from genome sequencing read depth in the UK Biobank. [PDF]
Garg P +4 more
europepmc +1 more source
Adipocytes influence choroidal neovascularization via PRDM16. [PDF]
Diaz-Marin R +6 more
europepmc +1 more source
Cognitive Neuroelectrical Activity During Preparation for Exercise Under Hyperthermia. [PDF]
Shibasaki M, Nakata H.
europepmc +1 more source
Breast cancer subtypes, estrogen receptor‐positive (ER+), HER2‐enriched, and TNBC, are defined by genomic and epigenetic signatures. Multi‐omics profiling, immunotherapy, liquid biopsy, and AI‐driven radiogenomics enable precision medicine. Tools like Oncotype DX and PAM50 support personalized care.
Samina Malik +4 more
wiley +1 more source
CNV-Hub: an integrated web-based platform for CNV classification and interpretation using multi-algorithm consensus. [PDF]
Pillay VGV +14 more
europepmc +1 more source
A microfluidic model of the glioblastoma (GBM) margin was developed to mimic patient‐specific blood‐brain tumor barrier (BBTB) function and drug response. The platform revealed inter‐patient variability in barrier integrity and drug sensitivity, offering a tool for personalized therapy evaluation in GBM.
Minsu Ryoo +16 more
wiley +1 more source
Genome sequencing-based CNV analysis in an infant with concurrent partial trisomies 9p and 12p due to maternal translocation: A case report. [PDF]
Azher Z +5 more
europepmc +1 more source

